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Abstract
Introduction: Vitamin D deficiency has been associated with increased risk of colorectal cancer (CRC), but causal
relationship has not yet been confirmed. We investigate the direction of causation between vitamin D and CRC by
extending the conventional approaches to allow pleiotropic relationships and by explicitly modelling unmeasured
confounders.
Methods: Plasma 25-hydroxyvitamin D (25-OHD), genetic variants associated with 25-OHD and CRC, and other relevant
information was available for 2645 individuals (1057 CRC cases and 1588 controls) and included in the model. We
investigate whether 25-OHD is likely to be causally associated with CRC, or vice versa, by selecting the best modelling
hypothesis according to Bayesian predictive scores. We examine consistency for a range of prior assumptions.
Results: Model comparison showed preference for the causal association between low 25-OHD and CRC over the reverse
causal hypothesis. This was confirmed for posterior mean deviances obtained for both models (11.5 natural log units in
favour of the causal model), and also for deviance information criteria (DIC) computed for a range of prior distributions.
Overall, models ignoring hidden confounding or pleiotropy had significantly poorer DIC scores.
Conclusion: Results suggest causal association between 25-OHD and colorectal cancer, and support the need for
randomised clinical trials for further confirmations.
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Introduction
In 1980, it was first hypothesised that vitamin D is a protective
factor against colorectal cancer (CRC) [1]. It has subsequently
been shown that higher vitamin D intake [2], higher serum 25-
hydroxyvitamin D (25-OHD) [3] and residence in regions with
strong UVB radiation [4] are all associated with lower CRC risk
and cancer death [5]. The majority of the available evidence
comes from ecologic correlations or observational studies.
Unbiased attempts to investigate causality in these studies are
unreliable, as study design cannot completely account for the effect
of potential confounders such as obesity or physical activity [6,7].
Nevertheless, experimental studies [8,9], randomized controlled
trials [2,10] and application of Hill’s criteria for causality [11,12]
support a possible causal role of vitamin D deficiency in colorectal
cancer. The volume of observational and in vitro evidence and the
potential large public health importance should associations prove
to be causal, require further investigation.
While awaiting results from randomised clinical trials, statistical
and machine learning methods allow the investigation of causality
in observational studies. One such method is Mendelian random-
ization (MR). MR is an application of instrumental variable (IV)
analysis that uses genetic polymorphisms as instruments
[13,14,15]. It has become increasingly more popular, since
genome-wide association studies (GWAS) identified numerous
genetic variants that can be used as ‘‘instruments’’ [16].
Conventional MR approaches assume that: (i) genotypes are
randomized; (ii) genetic variants considered as instruments affect
the outcome only by modifying the biomarker, i.e. there are no
pleiotropic effects of these variants on the outcome; (iii) variations
between true and observed biomarkers are negligible (no
observation noise) [17,18,19,20]. If these assumptions hold,
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inference of causality from observational data is theoretically valid,
although conclusions are sensitive to the chosen instruments [21]
and may not be valid when the effects of the instruments on the
biomarkers are weak. Despite their popularity, it has been argued
that MR methods push the problem of causal inference to another
realm, as their assumptions are generally unverifiable [22]. For
example, it is rarely possible to exclude pleiotropy or estimate
effects of such exclusions on the resulting estimate, especially for
multiple instruments [23,24]. Also, in classic MR it is difficult to
assess how the causal estimates are affected by different
assumptions about distributions of the latent confounders.
Another important limitation of MR is that it lacks a formal
model comparison framework for inferring the direction of causality
when pleiotropy and confounding cannot be excluded as possible
explanations. The classic approach estimates the size of the causal
effect [25], but does not assess the relative value of causal vs.
reverse causal explanations. This may not matter in a long-term
cohort study where the temporal sequence from biomarker to
outcome is clear, but it limits the ability to infer causality from
cross-sectional or case-control data. Also note that in pleiotropic
models the causal and reverse models are not nested, and classical
tests for nested cannot be easily used. A more general approach to
learning the direction of causality is the Likelihood-based
Causality Model Selection (LCMS) method suggested by [26],
who propose selection of the best modelling hypothesis by
comparing likelihood-based scores for direct causal, reverse, and
pleiotropic models. While this approach relaxes the assumption of
no pleiotropy of the classic MR method, it does not allow for latent
confounders or measurement noise. Additionally, because their
method is not Bayesian, it cannot be easily scaled to large
problems where high-dimensional genotypes and/or phenotypes
are used as instruments.
We have previously performed a MR analysis to investigate the
possible causal effect of plasma 25-OHD on colorectal cancer risk
[27]. Our results were inconclusive and a causal relationship
between low 25-OHD and CRC was neither clearly demonstrated
nor excluded.
In this study, we set out to investigate the causal effect of 25-
OHD on colorectal cancer risk. We extend conventional
approaches (MR and LCMS) by: (i) allowing pleiotropic links
between the instruments and disease, (ii) accounting for the noise
in the measurement and (iii) modelling of ‘‘hidden confounders’’,
i.e. unmeasured factors that can affect biomarker and disease. We
proceed by selecting the best modelling hypothesis according to
Bayesian predictive scores, and investigate its consistency for a
broad range of prior assumptions. Our approach builds on the
strengths of MR and LCMS but relaxes their restrictive
assumptions, which results in models that better fit the data
according to the considered criteria.
Methods
We studied a subset of individuals from the SOCCS Study
(1999–2006) [27,28]. In total, 2645 individuals with all relevant
measurements available were included in this study (1057 cases
and 1588 controls). Ethical approval for the SOCCS study was
obtained from the MultiCentre Research Ethics committee for
Scotland (reference number 01/0/05) and from the Research and
Development Office of NHS Lothian (reference number 2003/
W/GEN/05). All participants gave informed written consent. The
subjects completed a questionnaire enquiring about lifestyle.
Questionnaire collected data on general medical history, physical
activity (hours of cycling and other sports activities, 4 groups),
socio-economic status (Carstairs Deprivation Index), smoking
habits, regular intake of aspirin and NSAIDs, height, weight,
and other. Participants also completed a semi-quantitative food
frequency (http://www.foodfrequency.org) and supplements ques-
tionnaires, which were used to calculate the vitamin D intake (see
[27,29]).
Total plasma 25-OHD (25-OHD2 and 25-OHD3), the main
storage form of vitamin D, was measured by liquid chromatog-
raphy-tandem mass spectrometry (LC-MS/MS) method [30]. 25-
OHD concentration was standardized to remove the prominent
effect of the season when blood was taken, and May-adjusted
measurement was used in the analyses (as described in [29]).
In this study, we used 16 SNPs associated with CRC in GWAS:
rs6691170, rs6687758, rs10936599, rs16892766, rs7014346,
rs10795668, rs3802842, rs7136702, rs11169552, rs4444235,
rs4779584, rs9929218, rs4939827, rs10411210, rs961253,
rs4925386 [31,32,33,34,35,36] and four SNPs associated with
25-OHD: rs2282679, rs12785878, rs10741657, rs6013897 [37].
We have reduced dimensionality of genetic factors to 6 principal
components.
Probabilistic Graphical Modelling
Relationships between biomarkers and outcomes can be
described by ‘‘Bayesian networks’’ represented by directed acyclic
graphs, where nodes correspond to random variables, edges
describe conditional independence structures, and every two nodes
are conditionally independent of each other given their parents.
Such models have been widely explored in statistical and machine
learning literature; their key advantage is that they can sometimes
be used to differentiate causality from mere statistical associations
[38,39,40].
As argued e.g. by MacKay (35.3, [41]), a Bayesian approach to
causality inference may be based on model selection, where models
describing different causal hypotheses are considered and com-
pared. For example, when priors on confounding and pleiotropic
effects are specified, the weight of evidence favouring a causal
model over an alternative one can be evaluated even though the
classical criteria for identification of causal effects in graphical
models [42,43] are not met. The fact that the same model is
selected for a broad range of domain-specific priors may indicate
the direction of causality (which may need to be further validated
through controlled experiments). This approach is attractive,
because it is applicable in real-world situations where both
confounding and pleiotropy may be present.
The graphical structure of the generic model considered in this
paper is shown on Figure 1. This extends the previously
introduced method of [44] by allowing for pleiotropic effects of
genotypes on biomarkers and outcomes. We consider several
variants of basic model, e.g. by reversing the direction of the link
between vitamin D and colorectal cancer, or removing it entirely.
For all such models, we compute likelihood-based scores which
indicate how well the model fits the data, in accordance with
recently introduced approach [45,46,47].
Outcome, Biomarker and Predictor variables. We ex-
amine the relationship between colorectal cancer (outcome, y) and
May-standardised plasma 25-OHD (biomarker, with the true
unobserved concentration denoted by x and the corresponding
noisy measurement denoted by xt) as shown on Figure 1. Note
that xt accommodates measurement error and biological oscilla-
tions. We account for known confounding by including the vector
of predictor variables g, which contains data on general and
environmental factors (age, sex, BMI, physical activity, family
history of CRC, NSAIDs intake, socio-economic status, total
caloric intake, alcohol intake, smoking, consumption of red meat
and dietary vitamin D intake) and genetic factors. Prior to the
Vitamin D and Colorectal Cancer
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analysis, all predictor variables were scaled to have: mean= 0 and
SD=1.
Unmeasured (or hidden) confounders. We assume that
joint effects of unmeasured confounders on biomarker and
outcome are approximately additive and may be summarized by
a hidden (latent) variable z (Figure 1), where z follows a Gaussian
distribution with mean= 0 and SD=1. Gaussianity of latent
factors is a standard assumption of mixed linear models [48] and
may be justified by the Central Limit theorem (which postulates
that the sum of a large number of independent effects is
approximately normally distributed, under certain conditions).
The constraint on the variance of the confounder is needed to
ensure identifiability of its effect on biomarkers and outcomes; we
choose it so that confounder z lies on the same scale as the scaled
predictor variables. During inference the confounder is margin-
alized out by computing averages over its probability distribution,
which is a standard way of accounting for hidden variables in
probability theory [41].
Model parameterization. Agakov et al. introduced the
Sparse Instrumental Variable method (SPIV) [46]. They assume
that all conditional distributions in the model shown on Figure 1
are linear Gaussians, with the inverse gamma priors on the
variances of noise terms, and sparsity-inducing Laplace priors on
coefficients of the linear mappings [46]. They consider the
maximum a posteriori approximation of inference; define an
expectation-maximization (EM) algorithm for fitting their model
to data, and use cross-validation to further tune hyperparameters.
We largely follow this construction, but assume a binary outcome
variable y (case/control) and a sparse logistic regression model for
the probability of CRC given the genotypes, biomarker, and
hidden confounders. Also, in contrast to [46], instead of using
point estimates of the parameters, we consider the more general
full Bayesian treatment approximated by Markov Chain Monte
Carlo (MCMC).
Priors/parameters. Similarly to [49] we considered zero-
mean Laplace priors on the linear coefficients with the concen-
tration hyperparameter gam1. Models with larger gam1 are more
likely to have their links pruned in the posterior mode (see Figure
S1).We investigate the relationship between CRC and 25-OHD
for a range of prior distributions (assuming gam1 is 0.025 unless
stated otherwise). The concentration around zero encodes our
belief that large genotypic and phenotypic effects are unlikely,
while the fat tails of the Laplace component allow for possible rare
large associations.
We denoted precisions (inverse variances) of linear predictors as
precx, precxt, precy and precz for the true 25-OHD, measurement of
25-OHD, effects on disease status, and unmeasured confounders
respectively. For these, we have used both fixed values for ensuring
identifiability of the random effects and indicative of our beliefs in
the magnitude of the observation noise, and the conjugate Gamma
priors. Smaller values of the precisions correspond to wider
confidence intervals associated with every measurement.
Probabilistic inference and model selection. Several
likelihood-based scores may in principle be considered [50,51].
Here we select the best model by using deviance information
criterion (DIC) readily computable from MCMC samples [51].
DIC balances quality of fit and complexity of a model, which helps
avoid overfitting. Preferred modelling hypotheses are character-
ized by lower DICs, providing the best combination of quality and
simplicity.
Models are compared by examining their DIC score differences.
Roughly, absolute differences of above 10 units definitely rule out
the model with the higher DIC, and differences between 5 and 10
are substantial [51,52]. We investigate consistency of the best
model under different assumptions about priors on the fixed effects
of the covariates, random effects of the confounders, and the
measurement noise. For the best such settings, we also compare
posterior means of the models’ deviances.
Experiments
In all experiments, we used the entire set of genotypic scores and
environmental factors associated with either CRC or 25-OHD.
The aim of experiment 1 was to determine the importance of
unmeasured confounders and their implication on the inference of
causality. We compared 3 models: the full causal model with
confounders (M1), the causal model without confounders (M2), and
the reverse model without confounders (M3) (Figure 2A). We
allowed for a possibility of pleiotropic dependencies where both
the biomarker and the outcome were affected by predictor
variables (the genotypes and environmental factors). The models
were then compared for a range of prior distributions and
Figure 1. Graphical representation of the basic model: y –
outcome (colorectal cancer, CRC); x – true concentration of the
biomarker, 25-OHD; xt – measured concentration of the
biomarker, 25-OHD; g – a vector of predictor variables: age,
sex, smoking, BMI, physical activity, family history, NSAIDs
intake, socioeconomic status, total caloric intake, alcohol
intake, consumption of red meat, dietary vitamin D intake
and SNPs associated with CRC or 25-OHD; z – unmeasured,
hidden confounders. Link u represents the effect of predictor
variables on 25-OHD, w is the effect of 25-OHD on CRC, wg is the effect
of predictor variables on the CRC, v is the effect of unmeasured
confounders on the 25-OHD and wz is the effect of unmeasured
confounders on colorectal cancer.
doi:10.1371/journal.pone.0063475.g001
Vitamin D and Colorectal Cancer
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assumptions about the observation noise, and the best modelling
hypothesis was selected based on the DIC score.
In experiment 2, we considered the noisy extensions of the
conventional causal (M4) and reverse (M5) models of the LCMS
approach [26,53] with a model where the association between the
biomarker and outcome was explained entirely by an unmeasured
confounder (M6), as shown on Figure 2B. The purpose of this
experiment was two-fold: (i) to demonstrate restrictiveness of the
assumption of no latent confounders in LCMS, and (ii) to show
that a Bayesian treatment of the classic instrumental variable
method [44] would not be able to identify causality by favouring a
non-causal over a causal explanation. As in experiment 1, we
selected the best model for a range of prior parameter settings.
The purpose of experiment 3 was to compare the full causal
and reverse models where the confounders were modelled
explicitly (Figure 2C). Note that both of these models are
likelihood-equivalent; e.g. for each setting of parameters of one
there exists a setting of parameters of the other which results in an
identical likelihood. The approach considered here handled such
symmetry by choosing the Laplace prior distribution on the
magnitudes of the linear effects, which encoded our prior belief
that very large genotypic and phenotypic effects are rare (see
Appendix S1).
In the exploratory phase of experiment 3, we considered
independent priors on the direct associations between the
biomarker and the outcome (gam1,w link) and the confounding
effects (gam2, v and wz links), which were made different in order to
further increase the flexibility of the method. A random sample of
500 cases and 500 controls was used to make an exploration of
different prior assumptions more efficient. We performed multiple
runs of the Markov chains from random initializations to account
for possible variations in the deviance scores (seeMethods S1 for
more details) for a broad range of prior distributions.
In the final phase of experiment 3, using the complete
dataset we compared the full causal (M7) and reverse (M8) models
where the confounders were modelled explicitly. We performed
multiple repetitions keeping sparsity parameter gam1 fixed to the
best value from the earlier low-dimensional phase, but varied
precisions to check consistency of the results.
Results
The study population is described in Table 1. Both crude and
May-standardised 25-OHD levels were strongly associated with
CRC in the univariate model (p = 1.2E-10 and 6.9E-9, respec-
tively), model adjusted for age and sex (p= 3.5E-10 and 2.9E-8,
respectively) and in fully adjusted model (p = 5.5E-10 and 2.0E-8,
respectively). Moreover, predicted vitamin D level (using all
covariates) was also associated with CRC (p= 0.048), suggesting
that chosen covariates are predictive of vitamin D and can indeed
be considered as valid candidate instruments. Results were
consistent when data was split into training and testing datasets
(data not shown).
Experiment 1. Importance of Confounders for the
Inference of Causality
For the first setting in Experiment 1, DIC scores for causal and
reverse causal models without confounders were DICM2= 42,132
and DICM3=41,911, respectively. The significantly lower DIC
score for reverse causal model (DIC difference = 221 units)
indicates its superiority over the causal model. However, DIC
score for the full causal model with confounders (M1) was
significantly lower (DICM1=23,797), yielding a very large DIC
difference of 45,929 and 45,708 units in support of M1, when
Figure 2. Graphical representation of models compared in
Experiments 1 to 3 are shown. A. Experiment 1. M1 - full causal
model with confounders, M2 - causal model without confounders, and
M3 - reverse model without confounders. B. Experiment 2. We
compare conventional causal (M4) and conventional reverse causal (M5)
models (both (i) assume absence of pleiotropic effects of instruments
on biomarkers and outcomes, (ii) explicitly exclude unmeasured
confounders from modelling and (iii) account for the noise in the
measurement) with the model where the association between the
biomarker and outcome is modelled entirely by unmeasured confound-
ers (M6). C. Experiment 3. We compare full causal (M7) and full
reverse causal model (M8), allowing for pleiotropic relationships and
accounting for hidden, unmeasured confounders.
doi:10.1371/journal.pone.0063475.g002
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compared to M2 and M3, respectively. Results were consistent
across all tested settings (Table 2). This suggests that the model
accounting for unmeasured confounders by far outperforms models
without confounders.
Experiment 2. Comparison with LCMS Models
DIC scores for the conventional causal and reverse causal
models considered by LCMS [26,53] were DICM4= 43,347 and
DICM5= 41,915, respectively, for the first setting in Experiment 2.
A DIC score difference of 1,432 in favour of M5 suggests that
reverse causal relationship between 25-OHD and CRC is more
likely. However, a model that assumes only an indirect association
between 25-OHD and CRC through unmeasured confounders
(M6), fits the data significantly better than either of the previous
models (M4 and M5), as is suggested by DIC score differences of
43,266 and 41,834 units, respectively. Results were consistent
across all tested settings (Table 3).
Experiment 3. Inference of Causality between Plasma 25-
OHD and CRC
In the exploratory stage of experiment 3, we performed 30
comparisons varying gam1 and gam2. Unsurprisingly, for sparser
Table 1. Study cohort.
Variable ALL CONTROLS CASES
N 2645 1588 1057
Age, years 62.8 (10.3) 62.9 (10.2) 62.6 (10.4)
Gender, % female 41.98 41.44 43.99
25-OHD, ng/ml 11.25 (6.96–16.94) 12.25 (7.60–18.00) 10.25 (5.94–15.36)
BMI 26.69 (4.50) 26.77 (4.67) 26.57 (4.24)
Physical Activity, N (%)
cat 1 1471 (55.61) 861 (54.22) 610 (57.71)
cat 2 686 (25.54) 415 (26.13) 271 (25.64)
cat 3 309 (11.68) 197 (12.41) 112 (10.60)
cat 4 179 (6.77) 115 (7.24) 64 (6.05)
Family health risk, N (%)
low 2471 (93.42) 1572 (98.99) 899 (85.05)
medium 158 (5.97) 15 (0.94) 143 (13.53)
high 16 (0.6) 1 (0.06) 15 (1.42)
NSAIDS, N (%)
yes 900 (34.03) 573 (36.08) 327 (30.94)
no 1745 1015 730
Carstairs Deprivation Index, N (%)
1 255 (9.64) 156 (9.82) 99 (9.37)
2 579 (21.89) 344 (21.66) 235 (22.23)
3 730 (27.6) 442 (27.83) 288 (27.25)
4 616 (23.29) 368 (23.17) 248 (23.46)
5 256 (9.68) 156 (9.82) 100 (9.46)
6 147 (5.56) 88 (5.54) 59 (5.58)
7 62 (2.34) 34 (2.14) 28 (2.65)
Energy intake, Kcal/day 2575 (982) 2521 (926) 2657 (1057)
Alcohol, g/day 7.9 (1.8–18.8) 8.1 (1.8–19.34) 7.6 (1.9–18.6)
Smoking, N (%)
never 1155 (43.67) 699 (44.02) 456 (43.14)
former 1062 (40.15) 617 (38.85) 445 (42.1)
current 428 (16.18) 272 (17.13) 156 (14.76)
Red meat, portion/day 1.24 (0.8–1.72) 1.23 (0.79–1.75) 1.25 (0.82–1.69)
Vitamin D (from food), mg/day 4.27 (3.16–5.79) 4.42 (3.24–5.95) 4.04 (3.06–5.59)
Vitamin D (from supplements), N (%)
.5 mg/day 151 (5.71) 85 (5.35) 66 (6.24)
.2.5 mg/day 498 (18.83) 307 (19.33) 191 (18.07)
Mean (standard deviation) or median (interquartile range) is shown for continuous variables and number (percent) is shown for categorical variables.
Physical activity is estimated from the reported hours of cycling and other sports activities (4 categories) and Carstairs Deprivation Index was used to describe socio-
economic status.
doi:10.1371/journal.pone.0063475.t001
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models (higher values of gam1) the difference in the scores of full
causal and reverse models becomes less significant. This is
intuitive, because for larger gam1 the models are approximately
decoupled, and any difference is largely due to the sampling noise
(Figure S1). Mean DIC was calculated for each gam1 setting, and
it was confirmed that dense models fit the data better (22801.12,
21816.54, 21598.58, 21571.33 and 21557.48, respectively).
When focusing on denser models (gam1#0.25), in 15/18
iterations there was overwhelming (DIC differences in the range
of 10.6 to 3,919) and in 2 substantial (DIC differences of 9.7 and
5.2) evidence in favour of the full causal model, and in one
iteration it was not possible to distinguish a preferred model with
certainty, although the causal model was favoured (DIC differ-
ence = 3.2 units) (Figure 3). Results of all comparisons are shown
in Table 4 and more detail in Table S1.
Finally, we used all available data to compare full causal and full
reverse causal models. We consistently observed evidence in
support of the direct causal relation between low 25-OHD and
CRC. Across all the noise parameter settings that we explored, the
full causal model provided a better explanation of data than the full reverse
causal model: DIC differences were between 580 and 10,715 units in
favour of the full causal model (Figure 4 and Table 5, for DIC
components see Table S2).
DIC scores computed here [51] generalize AIC scores used for
inferring the direction of causality in LCMS [26,53]. However, it
has been argued that they may underpenalize model complexity
[50]. By assuming that the full reverse model has approximately
the same complexity as the full causal model, we additionally
compared the best of the causal and reverse models according to
their mean posterior deviances (Dbar). (Note that 21/2 Dbar may
also be viewed as the ‘‘cooling limit’’ of thermodynamic
integration used for approximating marginal likelihoods of the
models [54]). Again, we found evidence of 11.5 natural log units in
favour of the causal model.
Note that this is opposite to the results found by explicitly
excluding the presence of hidden confounding (experiments 1 and
2); however, we have shown that according to the DIC scores, the
models allowing for hidden confounders resulted in better
explanations of the data than the models that did not allow for
confounders. We also consistently observed that lower levels of 25-
OHD are associated with CRC case status. Together, these results
suggest that low plasma 25-OHD levels may be causally associated
with CRC risk.
Discussion
In this paper, we show evidence in support of a causal
relationship between low plasma 25-OHD and colorectal cancer
risk. The study was conducted by implementing novel method-
ology that extends the conventional instrumental variable
approach and the more recent, likelihood-based causality model
selection method [26], by accounting both for confounding by
unknown factors and allowing pleiotropic relationships.
SPIV and Improvement in the Methodology
Conventional approaches to the problem of causal inference are
based on strong and often unrealistic assumptions about data. In
practice such assumptions may be violated, which can lead to poor
models and biased causal estimates [22,55]. If one carefully selects
instruments or sub-samples data to approximately satisfy the
restrictive assumptions, inference in MR and LCMS is mathe-
matically sound, but the results will generally be sensitive to the
selections and can lead to varying conclusions [21,46,56]. In this
paper we apply a different, model selection based strategy called
SPIV, where we jointly consider genotypic factors predictive of
either biomarkers or outcomes without relying on strong
assumptions of the classical methods. The fact that the same ‘‘full
causal’’ model explains the data better than alternative modelling
hypotheses as shown for a broad range of domain-supported prior
distributions is indicative of possible causality and justifies further
controlled experiments.
Table 2. Likelihood-based deviance information criterion
(DIC) scores for 3 models compared in Experiment 1 are
shown.
MODEL setting 1 setting 2 setting 3
full causal
model with
confounders
23,797** 22,547** 23,003**
causal model
without
confounders
42,132 212,173 21,300
reverse causal
model without
confounders
41,911 210,996 21,183
DIC has been computed from MCMC samples; preferred modelling hypotheses
are characterized by lower DICs. The full causal model with confounders (M1)
suggests causal relationship between 25-OHD and colorectal cancer and also
models hidden confounding, causal model without confounders (M2) also
proposes causal relationship, but hidden confounding is disregarded, and
reverse model without confounders (M3) proposes that colorectal cancer leads
to lower levels of 25-OHD, also ignoring hidden confounding. Digits after
decimal point have been omitted from the table for clarity.
Setting 1: precxt= 200, precx= 200, precy=100; Setting 2: precxt= 1000,
precx= 1000, precy= 0.1; Setting 3: precxt=100, precx=100, precy=100. Sparsity
parameter gamma is set to 0.025 in all models. In model with confounders (M1),
precz=1.
**indicates the best model for each setting.
doi:10.1371/journal.pone.0063475.t002
Table 3. Likelihood-based deviance information criterion
(DIC) scores for conventional causal (M4) and conventional
reverse causal (M5) models, both (i) assume absence of
pleiotropic effects of instruments on biomarkers and
outcomes, (ii) explicitly exclude unmeasured confounders
from modelling and (iii) account for the noise in the
measurement; and for the model where the association
between the biomarker and outcome is modelled entirely by
unmeasured confounders (M6); these models have been
compared in Experiment 2.
MODEL setting 1 setting 2 setting 3
conventional causal
(without confounders)
43,347 218,230 21,883
conventional reverse
(without confounders)
41,915 211,254 21,189
no causal link but accounting
for unmeasured confounders
81** 21,549** 689**
Digits after decimal point have been omitted from the table.
Setting 1: precxt=200, precx= 200, precy=100; Setting 2: precxt=1000,
precx= 1000, precy= 0.1; Setting 3: precxt=100, precx=100, precy=100. Sparsity
parameter gamma is set to 0.025 in all models. In model with confounders (M6)
precz= 1.
**indicates the best model for each setting; preferred modelling hypotheses are
characterized by lower DICs.
doi:10.1371/journal.pone.0063475.t003
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The model selection based strategy underlying SPIV was
advocated by some of the most prominent machine learning
scientists [41], applied by Schadt et al. for a subset of models [26],
further developed by Agakov et al. [46], and recently theoretically
investigated by Winn [57]. It offers important extensions of the
common methodology and may be used even in situations where
relationships are pleiotropic or confounded by unknown/unmea-
sured factors (see Table 6 and Appendix S1 for more detail).
Our approach can accommodate models underlying the conven-
tional methods as limiting special cases.
We have previously described an inverse association between
plasma 25-OHD concentration and CRC in this study population.
However, results of Mendelian randomisation study we conducted
were inconclusive [27].
In this study, by applying SPIV we consistently observed
evidence in support of the direct causal relation between low 25-
OHD and an increased risk of CRC, when pleiotropic and
confounding effects were modelled explicitly, which is in
agreement with previous work [58,59]. Such inference became
possible by relaxing the strong assumptions of common approach-
es and exploiting Bayesian model selection. Our results were
consistent for a wide range of biologically plausible zero-centred
heavy-tailed prior distributions.
We also show that models ignoring hidden confounders or
pleiotropy have significantly worse likelihood-based scores then
models accounting for them. This raises the question of reliability
of causal inference in weaker models that ignore confounding
and/or pleiotropy. Experiment 2 showed that the causal and
reverse models considered by LCMS [26,53] are inferior to models
allowing for latent confounding. This also shows that Bayesian
treatment of classic MR [44] would not be able to infer causality
and would favour a non-causal explanation through confounders.
Limitations and Future Work
An important limitation of our study is that only a small number
of genotypes and environmental covariates were used as instru-
ments, while there is overwhelming evidence that complex traits
may potentially be explained by a very large number of common
SNPs [60]. Future studies should consider employing larger
number of genetic markers as instruments. Note that while high-
dimensional instruments may be integrated into our framework
relatively easily, this is less easy in the classic non-Bayesian
methods due to the problems with weak instruments and possible
overfitting [23,24,26,53].
Another limitation of our strategy is that, in contrast to the
standard approaches to causality, it does not formally guarantee
equivalence of the causal ‘‘do-calculus’’ to probabilistic inference.
However, our approach makes more realistic assumptions about
the data and results in stronger models of the underlying
phenomena, which is manifested by significantly better likeli-
hood-based scores than models underlying the standard methods.
In situations when the underlying models generating the data were
Figure 3. Likelihood of causal association between low 25-OHD and colorectal cancer is compared with the reverse causal
hypothesis, (proposing CRC leads to lower 25-OHD), in a subset of data comprising a random sample of 500 cases and 500
controls. DIC score differences arising from the comparison of the full causal and reverse causal models, for a range of parameter settings are shown.
Positive values indicate preference for the causal model. Mean DIC (black line) represents the average DIC for all causal and reverse causal models
considered (lower mean DIC scores suggest better models), for any given setting of sparsity gam1 parameter (higher gam1 favours sparser models -
links between nodes are increasingly more likely to be pruned). We consider independent gamma priors on the associations concerning confounding
effects (gam2) in order to attenuate the strong effect of confounder and to artificially boost the importance of the link between 25-OHD and
colorectal cancer. Overall, optimal models are the denser ones (characterised by smaller values of gam1 parameter, most links remain in the model),
and large positive DIC differences provide overwhelming evidence for a direct causal relation between low 25-OHD and colorectal cancer.
doi:10.1371/journal.pone.0063475.g003
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Table 4. Likelihood of causal association between low 25-OHD and colorectal cancer (M7) is compared with the reverse causal
hypothesis (proposing CRC leads to lower 25-OHD, M8), in a subset of data comprising a random sample of 500 cases and 500
controls.
gam2
0.1 0.5 1.0 3.0 10.0 20.0
gam1 MODEL DIC difference DIC difference difference DIC difference DIC difference DIC difference
mean
DIC
0.025 causal 24415.1 21663.6 25545.9 23414.2 23707.8 25481.7
reverse 21563.2 21565.4 21564.4 21564.3 21565.4 21562.4
2851.9 98.2 3981.5 1849.9 2142.4 3919.3 22801.1
0.1 causal 21884.7 23511.6 21727.2 21944.3 21773.4 21568.8
reverse 21567.3 21560.6 21574.4 21565.2 21561.8 21559.1
317.4 1951.0 152.8 379.1 211.6 9.7 21816.5
0.25 causal 21569.3 21572.8 21892.8 21565.6 21623.8 21579.4
reverse 21564.1 21562.2 21565.1 21562.4 21563.3 21562.3
5.2 10.6 327.7 3.2 60.5 17.1 21598.6
1 causal 21568.4 21569.5 21582.2 21568.3 21565.6 21564.1
reverse 21591.7 21580 21566.3 21574.2 21563.9 21561.9
223.3 210.5 15.9 25.9 1.7 2.2 21571.3
10 causal 21556.4 21558.8 21557.7 21558.4 21554.7 21555.5
reverse 21559.0 21564.9 21557.7 21564.2 21554.1 21548.4
22.6 26.1 20.1 25.8 0.6 7.1 21557.5
Deviance information criterion (DIC) score differences between twomodels are shown for a range of parameter settings; positive values indicate preference for the causal model.
Mean DIC represents the average DIC including all causal and reverse causalmodels considered (lower mean DIC scores suggest better models), for any given setting of sparsity gam1
parameter (higher gam1 favours sparser models - links between nodes are increasingly more likely to be pruned). We consider independent gamma priors on the associations
concerning confounding effects (gam2) in order to attenuate the strong effect of confounder and to artificially boost the importance of the link between 25-OHD and colorectal
cancer. Overall, optimal models are the denser ones (characterised by smaller values of gam1 parameter, most links remain in the model), and large positive DIC differences provide
overwhelming evidence for a direct causal relation between low 25-OHD and colorectal cancer. Details on DIC components are in Table S1.
*Noise parameters are set to: precxt= 1000, precx= 1000, precy=0.1.
doi:10.1371/journal.pone.0063475.t004
Figure 4. Likelihood of causal association between low 25-OHD and colorectal cancer is compared with the reverse causal
hypothesis, (proposing CRC leads to lower 25-OHD), on the complete dataset and for a range of parameter settings. DIC score
differences between models are shown; positive values indicate that causal association is more likely. Mean DIC (red line) is calculated as the average
DIC for all causal and reverse causal models considered for any given parameter setting (smaller values indicate better models). Large positive DIC
differences provide overwhelming evidence for a direct causal relation between low 25-OHD and colorectal cancer. * Settings: S1: precx = 1000,
precxt = 1000, precy = 0.1; S2: precx = 100, precxt = 100, precy = 100; S3: precx = 1000, precxt = 1000, precy = 10; S4: precx = 100, precxt = 100,
precy = 200; S5: precx = 20, precxt = 20, precy = 200.
doi:10.1371/journal.pone.0063475.g004
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known, the model selection approach similar to the one presented
here has shown excellent quality of reconstruction of the
underlying relationships (e.g. [46]; see also [26,53] for earlier
studies excluding latent variables where the biomarkers were gene
expressions, and [57] for a recent theoretic formalization of the
model selection approach to causal inference).
In the proposed Bayesian approach, inference is affected by
prior distributions. This was partially mitigated by considering
multiple such priors within the considered super-Gaussian family
encoding sparsity in the posterior modes and allowing for rare
large effects. In the future, other priors may be considered and
effects investigated for a broader range of different assumptions
about hyperparameters.
In this paper we have selected the best model by using the DIC
criterion that balances predictive accuracy and model complexity.
The DIC generalizes the Akaike Information Criterion [51], is
easily available for MCMC samples, and often used in epidemi-
ology [61]. The DIC scores consistently indicate preference for a
causal hypothesis across the range of the considered priors. Also,
for most of the considered settings, the DIC has resulted in a
positive complexity estimate (pD, see Table S1). However, for
other settings, the DIC may not be an accurate score, which may
be the case e.g. for multi-modal posteriors [50,62]. Other selection
scores, e.g. the ones based on annealed importance sampling [63]
and thermodynamic approximations of Bayes factors [54,64]
developed in statistical physics should be considered in the future,
although they are significantly more expensive to compute. One
technical limitation is the computational cost of the MCMC
approximation of the Bayesian inference, which may be addressed
in the future by considering alternative approaches to approximate
inference [65].
Finally, it is currently unclear if colorectal cancer progression (or
treatment) affects 25-OHD concentration. Our data has been
collected at a single time point after the diagnosis. The apparent
causal relationship suggested by this work may be further validated
by collecting multiple temporally repeated measurements and
replicating the analysis.
Conclusion
Extended instrumental variable analysis (SPIV) indicates a
causal association between low plasma 25-OHD and colorectal
cancer risk. Our findings support the need for randomised clinical
trials aimed at a further assessment of the role of vitamin D in
colorectal cancer risk and suggest that investment in this field may
be justified. With rising interest in instrumental variable
approaches and Mendelian randomisation, it is important to be
aware of the method limitations and requirements; failure to do so
may seriously bias the inference of causality.
Supporting Information
Figure S1 Examples of A. dense, B. sparse and C. decoupled
models. The effect of increasing values of gamma sparsity
parameter and consequential disappearing of the links in the
model finally results in the decoupled model when gamma is large
(eg. 10).
(TIF)
Table S1 Likelihood of causal association between low 25-OHD
and colorectal cancer (M7) is compared with the reverse causal
hypothesis (proposing CRC leads to lower 25-OHD, M8), in a
subset of data comprising a random sample of 500 cases and 500
controls. DIC score differences between two models are shown for
a range of parameter settings; positive values indicate preference
for the causal model. Mean DIC represents the average DIC
including all causal and reverse causal models considered (lower
mean DIC scores suggest better models), for any given setting of
sparsity gam1 parameter (higher gam1 favours sparser models -
links between nodes are increasingly more likely to be pruned). We
consider independent gamma priors on the associations concern-
ing confounding effects (gam2) in order to attenuate the strong
effect of confounder and to artificially boost the importance of the
link between 25-OHD and colorectal cancer. Overall, optimal
Table 5. Likelihood of causal association between low 25-
OHD and colorectal cancer is compared with the reverse
causal hypothesis (proposing CRC leads to lower 25-OHD), on
the complete dataset and for a range of parameter settings.
setting
S1 S2 S3 S4 S5
DIC causal 210,480 211,074 24,242 22,203 3,004
DIC reverse 24,161 2358 23,661 1,115 5,214
DIC difference 6,319 10,715 580 3,318 2,210
mean DIC 27,321 25,716 23,952 2544 4,109
Deviance information criterion (DIC) score differences between models are
shown; positive values indicate that causal association is more likely. Mean DIC
is calculated as the average DIC for all causal and reverse causal models
considered for any given parameter setting (smaller values indicate better
models). Large positive DIC differences provide overwhelming evidence for a
direct causal relation between low 25-OHD and colorectal cancer. Details on DIC
components are in Table S2. Digits after decimal point have been omitted
from the table.
*Settings: S1: precx = 1000, precxt = 1000, precy = 0.1; S2: precx = 100,
precxt = 100, precy = 100; S3: precx = 1000, precxt = 1000, precy = 10; S4:
precx = 100,precxt = 100, precy = 200; S5: precx = 20, precxt = 20, precy = 200.
doi:10.1371/journal.pone.0063475.t005
Table 6. Comparison of the Sparse Instrumental Variable
approach (SPIV) with Likelihood-based Causality Model
Selection (LCMS) and Mendelian Randomization (MR).
SPIV LCMS MR
Pleiotropy yes yes no
Latent confounding yes no yes
Observation noise yes1 no no
Model selection yes yes no2
Weak instruments3 yes no no
1By observation noise we mean variations between true and observed
biomarkers, and their different treatment in the underlying models.
2Model selection implies probabilistic model comparison based on likelihood
scores that can be used, for example, to infer the direction of causality. Note
that while the classic MR can be used to compute p-values for causal and
reverse models Timpson et al. (2011), it cannot be easily used to assess relative
value of causal vs reverse causal explanations. In classic MR, formal and fair
comparisons are further complicated by the fact that the causal and reverse
models are not nested and use non-overlapping sets of instruments. The more
recent Bayesian treatment of MR suggested by McKeigue et al. (2010) can in
principle be used for model selection, but is limited to selecting either the
conventional causal or non-causal explanation under the assumption of no
pleiotropy.
3Because SPIV is Bayesian and can use prior information to break symmetries
between causal and reverse models, it can be used to infer the direction of
causality even if only weak instruments are available.
doi:10.1371/journal.pone.0063475.t006
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models are the denser ones (characterised by smaller values of
gam1 parameter, most links remain in the model), and large
positive DIC differences provide overwhelming evidence for a
direct causal relation between low 25-OHD and colorectal cancer.
(DOC)
Table S2 Likelihood of causal association between low 25-OHD
and colorectal cancer is compared with the reverse causal
hypothesis (proposing CRC leads to lower 25-OHD), on the
complete dataset and for a range of parameter settings. DIC
components for both models are shown. Mean DIC is calculated
as the average DIC for all causal and reverse causal models
considered for any given parameter setting (smaller values indicate
better models). Large positive DIC differences provide over-
whelming evidence for a direct causal relation between low 25-
OHD and colorectal cancer.
(DOC)
Methods S1
(DOCX)
Appendix S1 On causality and improvement over con-
ventional methods.
(DOCX)
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